Company / Debt per Share
Niagen Bioscience, Inc. Debt per Share History
FY2016-FY2016 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Debt per Share
-
FY2016
5-year range
-
FY2016-FY2016
Trend
-100.0%
vs FY2015
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Debt per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Company context
Key Data Points
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Debt per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | - | - |
| FY2023 | - | - |
| FY2022 | - | - |
| FY2021 | - | - |
| FY2020 | - | - |
| FY2019 | - | - |
| FY2018 | - | - |
| FY2017 | - | - |
| FY2016 | $0.00 | -100.0% |
As of FY2016 · SEC 10-K · Updated Jun 28, 2026